Form D · Other Health Care
SECOND SIGHT MEDICAL PRODUCTS INC
Sylmar, CA · CIK 0001266806
Offering snapshot reported Apr 7, 2021 · SEC filing
- Reported sold
- $27.9M Offering amount: $27.9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 7, 2021 | Initial | $27,900,000 | No comparison | 7 | SEC filing |
| Dec 21, 2018 | Initial | $2,999,991 | No comparison | 2 | SEC filing |
| Oct 23, 2018 | Initial | $3,997,718 | No comparison | 2 | SEC filing |
| Aug 17, 2018 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| May 8, 2018 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Jul 18, 2014 | Amendment | $11,000,000 | No comparison | 5 | SEC filing |
| Jun 25, 2014 | Amendment | $6,000,000 | No comparison | 0 | SEC filing |
| Jul 23, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 28, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 17, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 10, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 13, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 29, 2012 | Initial | $2,000,000 | No comparison | 0 | SEC filing |
| Feb 29, 2012 | Initial | $2,000,000 | No comparison | 0 | SEC filing |
| Jul 29, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 29, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 13, 2011 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Dec 30, 2010 | Initial | $1,900,000 | No comparison | 10 | SEC filing |
| Dec 30, 2010 | Initial | $3,500,000 | No comparison | 10 | SEC filing |
| Sep 7, 2010 | Initial | $1,500,000 | No comparison | 10 | SEC filing |
| Sep 2, 2010 | Initial | $5,000,000 | No comparison | 19 | SEC filing |
| May 8, 2006 | Paper | Not reported | No comparison | Not reported | |
| May 2, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.81M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-394867
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ThinkEquity, a division of Fordham Financial Management, Inc. | 20996 |
Source: Form D, filed Apr 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John T. Blake | Executive |
| Scott Dunbar | Executive |
| Tom Fogarty | Director |
| Tom Fogerty | Director |
| Robert Greenberg | Director, Executive |
| Bill Link | Director |
| William Link | Director |
| Kathy London | Executive |
| Alfred Mann | Director |
| Jonathan Will Mc Guire | Director |
| Aaron Mendelsohn | Director |
| Aaron Mendelsohon | Director |
| Matthew Pfeffer | Director |
| Edward Sedo | Executive |
| Gregg Williams | Director |
| Gregg Willilams | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
13170 Telfair Avenue
Sylmar, CA, 91342
Sylmar, CA, 91342